Ultragenyx Pharmaceutical Inc. Stock Performance
as on September 15, 2025 at 7:39 pm IST
Day's High
$29.57$30.32.47%
Upside
52 Week's Low
52 Week's High
$25.81$60.37
12.72%
Downside
104.16%
Upside
Ultragenyx Pharmaceutical Inc. share price movements today
- Previous Close
- $30.31
- Open
- $30.23
- Volume
- 73.2K
- Day's Low - High
- $29.57 - $30.3
- 52 Week Low - High
- $25.81 - $60.37
Ultragenyx Pharmaceutical Inc. Historical Returns
- 1 Month Return
- + 2.09 %
- 3 Month Return
- -19.15 %
- 1 Year Return
- -48.4 %
- 3 Year Return
- -35.89 %
- 5 Year Return
- -62.69 %
Ultragenyx Pharmaceutical Inc. Stock Fundamentals & Key Indicators
Check Ultragenyx Pharmaceutical Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.9B
EPS (TTM)
-5.0583
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-8.97
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
-0.24
EBITDA
-469.6M
Revenue (TTM)
610.2M
Profit Margin
-87.34%
Return On Equity TTM
0.00%
Ultragenyx Pharmaceutical Inc. Stock Valuation
Track how Ultragenyx Pharmaceutical Inc. P/E has moved over time to understand its valuation trends.
Ultragenyx Pharmaceutical Inc. in the last 5 years
Lowest (0.00x)
September 15, 2025
Today (-8.97x)
September 15, 2025
Industry (10.13x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -8.97x
Ultragenyx Pharmaceutical Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Ultragenyx Pharmaceutical Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.9B | -62.69% | -8.97 | -87.34% | |
| BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
| BUY | $59.4B | -3.43% | 14.11 | 31.37% |
Stock Returns calculator for Ultragenyx Pharmaceutical Inc. Stock including INR - Dollar returns
The Ultragenyx Pharmaceutical Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ultragenyx Pharmaceutical Inc. investment value today
Current value as on today
₹55,326
Returns
Returns from Ultragenyx Pharmaceutical Inc. Stock
Dollar Returns*
₹4,985 (+4.99%)
Analyst Recommendation on Ultragenyx Pharmaceutical Inc. Stock
Based on 27 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Ultragenyx Pharmaceutical Inc.. Average target price of $86.89
Ultragenyx Pharmaceutical Inc. Share Price Target
Get share price movements and forecasts by analysts on Ultragenyx Pharmaceutical Inc..
What analysts predicted
65.97%UPSIDE
Target Price
$86.89
Current Price
$29.57
Analyzed by
27 Analysts
Target
$86.89
Ultragenyx Pharmaceutical Inc. target price $86.89, a slight upside of 65.97% compared to current price of $29.57. According to 27 analysts rating.
Ultragenyx Pharmaceutical Inc. Stock's Interest Amongst Investors
Search interest for Ultragenyx Pharmaceutical Inc. Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Ultragenyx Pharmaceutical Inc. Quarterly Profit & Loss
All numbers in Millions USD
Ultragenyx Pharmaceutical Inc. Annual Profit & Loss
All numbers in Millions USD
Ultragenyx Pharmaceutical Inc. Quarterly Cash Flow
All numbers in Millions USD
Ultragenyx Pharmaceutical Inc. Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Ultragenyx Pharmaceutical Inc.
Insights on Ultragenyx Pharmaceutical Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, -151.08M → -114.95M (in $), with an average increase of 31.4% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 139.29M → 166.49M (in $), with an average increase of 16.3% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 124.0%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 159.4%
NEGATIVE IMPACTPrice Dip
In the last 7 days, RARE stock has moved down by -3.8%
About Ultragenyx Pharmaceutical Inc.
| Organisation | Ultragenyx Pharmaceutical Inc. |
| Headquarters | 60 Leveroni Court, Novato, CA, United States, 94949 |
| Industry | Health Technology |
| CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Ultragenyx Pharmaceutical Inc.
Name | Title |
|---|---|
Dr. Emil D. Kakkis M.D., Ph.D. | Founder, President, CEO & Director |
Mr. John Richard Pinion II | Chief Quality Operations Officer & Executive VP of Translational Sciences |
Mr. Theodore A. Huizenga | Senior VP, Corporate Controller & Principal Accounting Officer |
Mr. Howard Horn | Executive VP of Corporate Strategy & CFO |
Mr. Erik Harris M.B.A. | Executive VP & Chief Commercial Officer |
Dr. Eric Crombez M.D. | Chief Medical Officer & Executive VP |
Ms. Karah Herdman Parschauer J.D. | Chief Legal Officer & Executive VP of Corporate Affairs |
Mr. Ernie W. Meyer | Chief Human Resources Officer & Executive VP |
Mr. Thomas R. Kassberg | Chief Business Officer & Executive VP |
Mr. Vimal Srivastava | Senior Vice President of Business Development & Alliance Management |
FAQs
What is Ultragenyx Pharmaceutical Inc. share price today?
Ultragenyx Pharmaceutical Inc. share price today is $29.57 as on . Ultragenyx Pharmaceutical Inc. share today touched a day high of $30.3 and a low of $29.57.
What is the 52 week high and 52 week low for Ultragenyx Pharmaceutical Inc. share?
Ultragenyx Pharmaceutical Inc. share touched a 52 week high of $60.37 on and a 52 week low of $25.81 on . Ultragenyx Pharmaceutical Inc. stock price today i.e. is trending at $29.57,which is 51.02% down from its 52 week high and 14.57% up from its 52 week low.
What is Ultragenyx Pharmaceutical Inc.'s market capitalisation today?
Ultragenyx Pharmaceutical Inc. market capitalisation is $0.00T as on .
How to invest in Ultragenyx Pharmaceutical Inc. Stock (RARE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Ultragenyx Pharmaceutical Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ultragenyx Pharmaceutical Inc. Shares that will get you 0.0507 shares as per Ultragenyx Pharmaceutical Inc. share price of $29.57 per share as on September 15, 2025 at 7:39 pm IST.
What is the minimum amount required to buy Ultragenyx Pharmaceutical Inc. Stock (RARE) from India?
Indian investors can start investing in Ultragenyx Pharmaceutical Inc. (RARE) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Ultragenyx Pharmaceutical Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ultragenyx Pharmaceutical Inc. share’s latest price of $29.57 as on September 15, 2025 at 7:39 pm IST, you will get 0.3382 shares of Ultragenyx Pharmaceutical Inc.. Learn more about
fractional shares .
What are the returns that Ultragenyx Pharmaceutical Inc. has given to Indian investors in the last 5 years?
Ultragenyx Pharmaceutical Inc. stock has given -62.69% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?